1. Catalogs
  2. Randox Laboratories
  3. LT252 Respiratory Multiplex Array

LT252 Respiratory Multiplex Array

LT252 Respiratory Multiplex Array

LT252 Respiratory Multiplex Array

Product catalog summary
Introduction
Respiratory tract infections (RTIs) are a major global health concern, causing significant morbidity and mortality. They are particularly prevalent in developing countries and can lead to severe illnesses such as pneumonia and bronchitis. The Respiratory Multiplex Array II is designed to rapidly detect 21 bacterial and viral pathogens responsible for these infections, aiding in accurate diagnosis and treatment.
Antibiotic Resistance
Antibiotic resistance is a growing problem, with pathogens like Streptococcus pneumoniae becoming resistant due to poor antibiotic stewardship. Accurate identification of pathogens is crucial for appropriate antibiotic use, as many RTIs are viral and do not require antibiotics.
Respiratory Multiplex Array II
This diagnostic tool uses multiplex PCR and biochip array hybridization to detect pathogens from a single sample in approximately 6 hours. It is CE marked for clinical use and offers high specificity and rapid results.
Protocol
The testing process involves four steps: extraction of RNA/DNA, amplification via multiplex PCR, hybridization to a biochip array, and detection using the Evidence Investigator analyzer.
Benefits
For laboratories, the array provides a cost-effective and rapid diagnostic tool. For patients, it offers a comprehensive infection profile, enabling precise treatment and potentially reducing hospital stays.
Clinical Data
Studies during the 2013 Hajj demonstrated the array's effectiveness in detecting co-infections and environmental pathogens, highlighting its utility in mass gatherings.
Product Features
The array is compatible with various sample types and includes features like anti-contaminant enzymes and optimized wash steps to reduce hands-on time.
Ordering Details
The Respiratory Multiplex Array II is available in specific sizes and configurations, with detailed ordering information provided by Randox Laboratories.
See more

Catalog excerpts

LT252 Respiratory Multiplex Array-1

Respiratory Multiplex Array II Rapid, simultaneous detection of 21 bacterial and viral pathogens of the upper and lower respiratory tract

 Open the catalog to page 1
LT252 Respiratory Multiplex Array-2

RESPIRATORY MULTIPLEX ARRAY II Rapid, simultaneous detection of 21 bacterial and viral pathogens within the upper and lower respiratory tracts INTRODUCTION Respiratory tract infections (RTI) are caused by many viral and bacterial pathogens and are the second most common cause of morbidity and mortality worldwide.1 Acute respiratory disease (ARD) accounts for more than 4 million deaths annually and are the leading cause of death in developing countries.2 Viral respiratory infections can occur in epidemics and can spread rapidly within communities across the globe. Every year, influenza causes...

 Open the catalog to page 2
LT252 Respiratory Multiplex Array-3

The Respiratory Multiplex Array is the most comprehensive diagnostic test for infections of both the upper and lower respiratory tracts, simultaneously detecting 21 bacterial and viral pathogens in nucleic acid extracted from a single sputum, lavage or nasopharyngeal sample. The assay is based on a combination of multiplex PCR and biochip array hybridisation. Innovative PCR priming technology permits high discrimination between multiple targets. A unique primer set is designed for each target which will hybridise to a complementary oligo-nucleotide probe spotted on a biochip discrete test region...

 Open the catalog to page 3
LT252 Respiratory Multiplex Array-4

BENEFITS OF THE RANDOX RESPIRATORY MULTIPLEX ARRAY II PRODUCT FEATURES • Rapid turnaround time of ~6 hours from extracted genomic nucleic acid to result • ompatible with various sample matrices including sputum, lavage and nasopharyngeal samples C BENEFITS TO THE LABORATORY • imultaneously identifying the most prevalent pathogens, both viral and bacterial, will provide a S rapid and more cost-effective diagnostic tool than current tests, which detect single pathogens • One step RT-PCR • Inclusion of anti-contaminant enzyme as additional control measure • Optimised wash steps to minimise hands-on-time...

 Open the catalog to page 4
LT252 Respiratory Multiplex Array-5

Mass gatherings, such as the Hajj increase the likelihood of the spread of infectious diseases. The Kingdom of Saudi Arabia annually hosts over 2 million Muslim pilgrims from around 184 countries during the Hajj pilgrimage, making it one of the largest and most culturally and geographically diverse mass gatherings in the world. Respiratory tract infections (RTIs) are the most common infection transmitted between pilgrims during Hajj, and most pilgrims develop RTIs during their few weeks stay in Makkah and Madinah. The Randox Respiratory Multiplex Array was used to screen for the presence of bacterial...

 Open the catalog to page 5
LT252 Respiratory Multiplex Array-6

Evidence Investigator Rapid, accurate and comprehensive molecular testing The Evidence Investigator is a compact, semi-automated bench top platform consolidating molecular diagnostics and immunoassay on a single platform with protein and DNA biochips. Utilising revolutionary Biochip Array Technology (BAT), the Evidence Investigator allows simultaneous detection of multiple analytes from a single sample for efficient and costeffective testing. The Evidence Investigator molecular package includes the following: • 1 x Evidence Investigator analyser platform • PC biochip software • Barcode scanner...

 Open the catalog to page 6
LT252 Respiratory Multiplex Array-7

Respiratory Multiplex Array 1. umla, A. et al. Emerging respiratory tract infections 4 Rapid point of care diagnostic tests Z for viral and bacterial respiratory tract infections – needs, advances, and future prospects. Lancet Infect Dis 2014. Available online: http://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(14)70827-8.pdf. Last accessed January 2016. 2. orum of International Respiratory Societies. Respiratory Diseases in the World. F Realities of Today – Opportunities for Tomorrow. Available online: http://www.theunion.org/what-wedo/publications/technica;/english/FIRS_report_for_web.pdf....

 Open the catalog to page 7
LT252 Respiratory Multiplex Array-8

Discover more: Randox Biosciences, 55 Diamond Road, Crumlin, County Antrim, BT29 4QY, United Kingdom T +44 (0) 28 9442 2413 F +44 (0) 28 9445 2912 E [email protected] W randoxbiosciences.com Information correct at time of print. Randox Laboratories Ltd. is a subsidiary of Randox Holdings Limited a company registered within Northern Ireland with company number N.I. 614690. VAT Registered Number: GB 151 6827 08. Product availability may vary from country to country. Please contact your local Randox representative for information. Products may be for Research Use Only and not for use in...

 Open the catalog to page 8

All Randox Laboratories catalogs and technical brochures

  1. Acusera 24.7

    24  Pages

  2. sdLDL-C

    8  Pages

  3. RX modena

    20  Pages

  4. RX misano

    20  Pages

  5. RX Daytona Plus

    20  Pages

  6. Rx Imola

    20  Pages

  7. RX Monaco

    20  Pages

  8. VeraSTAT-V

    16  Pages

  9. VERASTAT

    16  Pages

  10. Qnostics

    52  Pages

  11. Linearity sets

    12  Pages

  12. Antioxidants

    16  Pages

  13. VIVALYTIC

    30  Pages

  14. HbA1c

    2  Pages

  15. Preparing QC

    1  Page

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.